SCHEMBL28110614

SCHEMBL28110614

NC(=O)OC1CCCCCC1

nearest known ligand 0.50

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 3/20 0.50
CA1 P00915 3/20 0.44
CA2 P00918 3/20 0.44
CA12 O43570 2/20 0.44
CA9 Q16790 2/20 0.44
CYP2C19 P33261 1/20 0.44
ATM Q13315 1/20 0.43
NAAA Q02083 2/20 0.42
HTT P42858 1/20 0.41
STS P08842 4/20 0.40
CYP19A1 P11511 1/20 0.39
MMP1 P03956 1/20 0.38
MMP9 P14780 1/20 0.38
MMP12 P39900 1/20 0.38
CES2 O00748 1/20 0.38
CES1 P23141 1/20 0.38
FABP7 O15540 1/20 0.37
FABP5 Q01469 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL113152 1.00 EPHX1 (0.50) EPHX1CA1CA2CA12CA9
SCHEMBL1416705 1.00 EPHX1 (0.50) EPHX1CA1CA2CA12CA9
SCHEMBL1416449 1.00 EPHX1 (0.50) EPHX1CA1CA2CA12CA9
Ammonia Solution, Strong SCHEMBL3387866 0.97 EPHX1 (0.48) EPHX1CA1CA2CA12CA9
Hydrochloric Acid SCHEMBL28839888 0.97 EPHX1 (0.48) EPHX1CA1CA2CA12CA9
SCHEMBL112091 0.97
Oxalic Acid SCHEMBL31534669 0.93 EPHX1 (0.45) EPHX1CA1CA2CA12CA9
SCHEMBL10067466 0.92 ATM (0.45) EPHX1CA1CA2CA12CA9
SCHEMBL113287 0.92
Cyclohexylamine SCHEMBL11585176 0.91 EPHX1 (0.44) EPHX1CA1CA2CA12CA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114026199-B Polarized light emitting film, polarized light emitting panel and display device containing water-soluble coumarin compound or salt thereof 日本化药株式会社 2023-12-26 CN disclosed
CN-103492370-B Substituted diaminocarboxamides and diaminocarbonitrile pyrimidines, compositions thereof, and methods of treatment therewith 西格诺药品有限公司 2016-10-26 CN disclosed